Elevation Oncology Inc
ELEV
Get informed when a big investor buys or sells
+ FollowMarket Cap$21.63M
Close$
$0.32
12.3% downside
Current Fair Value
12.3% downsideOvervalued by 12.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $21.63 Million |
|---|---|
| Enterprise Value | $-38,374,691.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.78 |
| Beta | 1.5 |
| Outstanding Shares | 59,173,854 |
Return
| Return on Equity | -102.69% |
|---|---|
| Return on Assets | -58.36% |
| Return on Invested Capital | -61.40% |
Valuation & Multiples
| P/E Ratio | -0.88 |
|---|---|
| PEG | -2.68 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.8 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 6.15% |
|---|---|
| Total Calls | 50,000▼ 23.08% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 49.92%▼ 7.27% |
|---|---|
| Total Invested | $10.84M▲ 23.74% |
| Investors Holding | 65▼ 7.00% |
ESG Score
No data
About Elevation Oncology Inc
8 employees